Skip to main content
Fig. 13 | Journal of Translational Medicine

Fig. 13

From: LncRNA RP3-525N10.2-NFKB1-PROS1 triplet-mediated low PROS1 expression is an onco-immunological biomarker in low-grade gliomas: a pan-cancer analysis with experimental verification

Fig. 13

Correlation Between PROS1 expression and Immune checkpoint inhibitors and immunomodulators. A Correlation between PROS1 and 150 immunomodulators ((chemokine (41), receptor (18), MHC (21), Immunoinhibitor (24) and Immunostimulator (46)). B Correlation analysis between PROS1 expression in Pan-cancer and immune checkpoint gene expression. C–G Correlation of SEMA3F expression with CD274 (C), CTLA4 (D), HAVCR (E), IDO1 (F), and PDCD1 G expression in LGG. *Significant correlation P < 0.05, **Significant correlation P < 0.01, ***Significant correlation P < 0.001

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us